Clinical trials
Fractures, Bone trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 5 |
| Suspended | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hadassah Medical Organization | 3 |
| Rabin Medical Center | 2 |
| Assaf-Harofeh Medical Center | 1 |
| BonusBio Group Ltd | 1 |
| Entera Bio Ltd. | 1 |
| HaEmek Medical Center, Israel | 1 |
| Hillel Yaffe Medical Center | 1 |
| Michal Roll PhD,MBA | 1 |
| Novo Nordisk A/S | 1 |
| Rambam Health Care Campus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fractures, Bone | 16 |
| Fractures, Closed | 2 |
| Hip Fractures | 2 |
| Acidosis, Lactic | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Ankle Fractures | 1 |
| Ankle Injuries | 1 |
| Cardiovascular Diseases | 1 |
| Coinfection | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.